These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38006031)

  • 1. Intradermal Vaccination against Influenza with a STING-Targeted Nanoparticle Combination Adjuvant Induces Superior Cross-Protective Humoral Immunity in Swine Compared with Intranasal and Intramuscular Immunization.
    Hernandez-Franco JF; Yadagiri G; Patil V; Bugybayeva D; Dolatyabi S; Dumkliang E; Singh M; Suresh R; Akter F; Schrock J; Renukaradhya GJ; HogenEsch H
    Vaccines (Basel); 2023 Nov; 11(11):. PubMed ID: 38006031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A split influenza vaccine formulated with a combination adjuvant composed of alpha-D-glucan nanoparticles and a STING agonist elicits cross-protective immunity in pigs.
    Patil V; Hernandez-Franco JF; Yadagiri G; Bugybayeva D; Dolatyabi S; Feliciano-Ruiz N; Schrock J; Hanson J; Ngunjiri J; HogenEsch H; Renukaradhya GJ
    J Nanobiotechnology; 2022 Nov; 20(1):477. PubMed ID: 36369044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.
    Dhakal S; Renu S; Ghimire S; Shaan Lakshmanappa Y; Hogshead BT; Feliciano-Ruiz N; Lu F; HogenEsch H; Krakowka S; Lee CW; Renukaradhya GJ
    Front Immunol; 2018; 9():934. PubMed ID: 29770135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the Efficacy of a Split Swine Influenza A Virus Nasal Vaccine Formulated with a Nanoparticle/STING Agonist Combination Adjuvant in Conventional Pigs.
    Patil V; Hernandez-Franco JF; Yadagiri G; Bugybayeva D; Dolatyabi S; Feliciano-Ruiz N; Schrock J; Suresh R; Hanson J; Yassine H; HogenEsch H; Renukaradhya GJ
    Vaccines (Basel); 2023 Nov; 11(11):. PubMed ID: 38006039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a novel functional porcine CD3
    Patil V; Yadagiri G; Bugybayeva D; Schrock J; Suresh R; Hernandez-Franco JF; HogenEsch H; Renukaradhya GJ
    Vet Immunol Immunopathol; 2024 Aug; 274():110785. PubMed ID: 38861830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Efficacy of Surface Coated versus Encapsulated Influenza Antigens in Mannose-Chitosan Nanoparticle-Based Intranasal Vaccine in Swine.
    Bugybayeva D; Dumkliang E; Patil V; Yadagiri G; Suresh R; Singh M; Schrock J; Dolatyabi S; Shekoni OC; Yassine HM; Opanasopit P; HogenEsch H; Renukaradhya GJ
    Vaccines (Basel); 2024 Jun; 12(6):. PubMed ID: 38932376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs.
    Thomas M; Wang Z; Sreenivasan CC; Hause BM; Gourapura J Renukaradhya ; Li F; Francis DH; Kaushik RS; Khatri M
    Vaccine; 2015 Jan; 33(4):542-8. PubMed ID: 25437101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyanhydride nanovaccine against swine influenza virus in pigs.
    Dhakal S; Goodman J; Bondra K; Lakshmanappa YS; Hiremath J; Shyu DL; Ouyang K; Kang KI; Krakowka S; Wannemuehler MJ; Won Lee C; Narasimhan B; Renukaradhya GJ
    Vaccine; 2017 Feb; 35(8):1124-1131. PubMed ID: 28117173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs.
    Dhakal S; Cheng X; Salcido J; Renu S; Bondra K; Lakshmanappa YS; Misch C; Ghimire S; Feliciano-Ruiz N; Hogshead B; Krakowka S; Carson K; McDonough J; Lee CW; Renukaradhya GJ
    Int J Nanomedicine; 2018; 13():6699-6715. PubMed ID: 30425484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intradermal vaccination with a phytoglycogen nanoparticle and STING agonist induces cytotoxic T lymphocyte-mediated antitumor immunity.
    Hernandez-Franco JF; Jan IM; Elzey BD; HogenEsch H
    NPJ Vaccines; 2024 Aug; 9(1):149. PubMed ID: 39152131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradermal immunization with inactivated swine influenza virus and adjuvant polydi(sodium carboxylatoethylphenoxy)phosphazene (PCEP) induced humoral and cell-mediated immunity and reduced lung viral titres in pigs.
    Magiri R; Lai K; Chaffey A; Zhou Y; Pyo HM; Gerdts V; Wilson HL; Mutwiri G
    Vaccine; 2018 Mar; 36(12):1606-1613. PubMed ID: 29454517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal Delivery of Inactivated Influenza Virus and Poly(I:C) Adsorbed Corn-Based Nanoparticle Vaccine Elicited Robust Antigen-Specific Cell-Mediated Immune Responses in Maternal Antibody Positive Nursery Pigs.
    Patil V; Renu S; Feliciano-Ruiz N; Han Y; Ramesh A; Schrock J; Dhakal S; HogenEsch H; Renukaradhya GJ
    Front Immunol; 2020; 11():596964. PubMed ID: 33391267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
    Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and local immune response in pigs intradermally and intramuscularly injected with inactivated Mycoplasma hyopneumoniae vaccines.
    Martelli P; Saleri R; Cavalli V; De Angelis E; Ferrari L; Benetti M; Ferrarini G; Merialdi G; Borghetti P
    Vet Microbiol; 2014 Jan; 168(2-4):357-64. PubMed ID: 24332702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal vaccination with replication-defective adenovirus type 5 encoding influenza virus hemagglutinin elicits protective immunity to homologous challenge and partial protection to heterologous challenge in pigs.
    Braucher DR; Henningson JN; Loving CL; Vincent AL; Kim E; Steitz J; Gambotto AA; Kehrli ME
    Clin Vaccine Immunol; 2012 Nov; 19(11):1722-9. PubMed ID: 22933397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cold-passaged isolates and bat-swine influenza a chimeric viruses as modified live-attenuated vaccines against influenza a viruses in pigs.
    Graaf A; Petric PP; Sehl-Ewert J; Henritzi D; Breithaupt A; King J; Pohlmann A; Deutskens F; Beer M; Schwemmle M; Harder T
    Vaccine; 2022 Oct; 40(43):6255-6270. PubMed ID: 36137904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Heterologous Prime-Boost Vaccination with H3N2 Influenza Viruses in Pre-Immune Individuals: Studies in the Pig Model.
    Chepkwony S; Parys A; Vandoorn E; Chiers K; Van Reeth K
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32882956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
    Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs.
    Borggren M; Nielsen J; Karlsson I; Dalgaard TS; Trebbien R; Williams JA; Fomsgaard A
    Vaccine; 2016 Jul; 34(32):3634-40. PubMed ID: 27211039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-lasting protective immunity against H7N9 infection is induced by intramuscular or CpG-adjuvanted intranasal immunization with the split H7N9 vaccine.
    Zhou Y; Li S; Bi S; Li N; Bi Y; Liu W; Wang B
    Int Immunopharmacol; 2020 Jan; 78():106013. PubMed ID: 31806571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.